Strategy Raises 2.7 Trillion to Buy BTC Even in a Bear Market [Decenter Market Status]

This article is machine translated
Show original

As of 8 AM on the 25th, BTC on Bithumb is trading at 160,807,000 won, down 0.47% from the previous day.


Despite the Bitcoin (BTC) downturn, Strategy is issuing preferred shares worth $20 billion (approximately 2.7474 trillion won) for additional purchases.

According to CoinMarketCap, a global virtual asset market tracking site, as of 8 AM on the 25th, BTC is trading at $118,673.91, down 1.02% from the previous day. Ethereum (ETH) dropped 2.85% to $3,614.90, XRP fell 9.96% to $3.176, and Solana (SOL) declined 6.42% to $189.13.



The domestic market shows a similar trend. At the same time, BTC on Bithumb is down 0.47% to 160,807,000 won. ETH dropped 0.30% to 5,058,000 won, XRP fell 2.13% to 4,314 won, and SOL declined 3.07% to 349,700 won.

Bloomberg reported that Strategy has expanded its preferred share issuance from $5 billion to $20 billion to raise funds for additional BTC purchases. The Series A perpetual preferred shares were priced at $90 per share at noon Eastern Time on Thursday. The initial dividend rate is reported to be 9%.

Previously, Bloomberg had forecast the share price would be between $90 and $95. Morgan Stanley, Barclays, TD Securities, and Moellis & Company are participating as joint lead managers. Strategy is the world's largest BTC holding company, with 607,770 Bitcoins.

The Fear and Greed Index from alternative asset data analysis firm Alternative.me is at 71 points, down 1 point from the previous day, indicating a "greed" state. The lower the index is toward 0, the more constrained the investment sentiment, while closer to 100 indicates market overheating.


Reporter Do Ye-ri
< Copyright โ“’ Decenter, Unauthorized Reproduction and Redistribution Prohibited >

Source
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments